The use of BRAF inhibitors demonstrated the principle susceptibility of melanoma to antiproliferative and proapoptotic therapies, suggesting researchers should search for strategies to further sensitize melanoma cells for apoptosis induction. This evidence concerns the gene BRAF and melanoma.